- Home
- Program
- English Program
English Program
- Plenary Lecture
- Semi-Pleanry Lecture
- East Asian Neurology Forum
- Neuroscience Frontier Symposium
- Overcome the Challenges of Neurological Disorders
- Hot Topics
- Symposium
- International Education Course
- Sponsored Seminar
- Presentation Award Session
- General Session (Oral)
- General Session (Poster)
Plenary Lecture
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 23 (Wednesday) 16:40～17:25 | |||||
| Room1 (Sapporo Geibunkan [Nitori Culture Hall] 1F) |
PL-01 | Plenary Lecture 01 | Hidehiro Mizusawa (National Center of Neurology and Psychiatry) | Martin Rossor (UCL, Institute of Neurology / NIHR, UK) | Meeting the Dementia Challenge in the UK |
Semi-Plenary Lecture
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 24 (Thursday) 14:20～15:05 | |||||
| Room2 (Sapporo Geibunkan [Zuisetsu] 3F) |
SPL-01 | Semi-Plenary Lecture 01 | Yoshikazu Ugawa (Fukushima Brain Disease Center) | Gregor K. Wenning (Medical University Innsbruck, Department of Neurology, Austria) | Multiple system atrophy |
East Asian Neurology Forum
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 23 (Wednesday) 09:50～11:50 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
EANF-1 | Current Findings on Acute Encephalitis via Flavivirus Infection: A form of Zoonosis | Hirofumi Sawa (Research Center for Zoonosis Control, Hokkaido University) Francisco Cardoso (Federal University of Minas Gerais, Brazil) |
Hidehiro Mizusawa (National Center of Neurology and Psychiatry) | Introduction |
| Eng Eong Ooi (Duke NUS Medical School, Programme in Emerging Infectious Diseases, Singapore) |
Flaviviral infection and the CNS | ||||
| Kentaro Yoshii (Laboratory of Public Health, Faculty of Veterinary Medicine, Hokkaido University) | Tick-borne encephalitis as a matter of public health | ||||
| Yasutaka Tajima (Department of Neurology, Sapporo City General Hospital) | TBE Clinical Features:clinico-pathological features of a Japanese case from central Hokkaido Island | ||||
| May 23 (Wednesday) 13:20～15:10 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
EANF-2 | Current Findings on Acute Encephalitis via Flavivirus Infection: A form of Zoonosis | Hirofumi Sawa (Research Center for Zoonosis Control, Hokkaido University) Francisco Cardoso (Federal University of Minas Gerais, Brazil) |
Roy A. Hall (Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Australia) |
New approaches to prevent diseases caused by West Nile virus and other mosquito-borne flaviviruses |
| Hirofumi Sawa (Research Center for Zoonosis Control, Hokkaido University / Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University) |
Examination of neuronal injury by West Nile virus infection | ||||
| Tadaki Suzuki (Department of Pathology, National Institute of Infectious Diseases) |
Pathological and epidemiological investigation for congenital Zika virus infection | ||||
| Satoko Otsu (WHO Viet Nam Country Office, Vietnam) |
Emerging infectious diseases (EIDs) preparedness and response: an example of Zika virus | ||||
Neuroscience Frontier Symposium
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 23 (Wednesday) 09:50～11:50 | |||||
| Room9 (Royton Sapporo [Regent Hall] 2F) |
NSF-01 | How neurons keep calm and carry on: roles of quality control in neurodegenerative diseases | Takafumi Hasegawa (Division of Neurology, Department of Neuroscience & Sensory Organs, Tohoku University Graduate School of Medicine) Mitsunori Fukuda (Graduate School of Life Sciences, Tohoku University) |
Wolfdieter Springer (Department of Neuroscience, Mayo Clinic Jacksonville / Mayo Clinic College of Medicine and Science, Graduate School of Biomedical Sciences, USA) | Molecular and cellular mechanisms of mitochondrial quality control in Parkinson's disease |
| Koji Yamanaka (Research Institute of Environmental Medicine, Nagoya University) | Collapse of mitochondria-associated membrane (MAM) as common pathomechanism for motor neuron disease | ||||
| Gunnar K. Gouras (Experimental Dementia Research Unit, Lund University, Lund, Sweden) | Endosomal-lysosomal pathway in Alzheimer's disease | ||||
| Mitsunori Fukuda (Graduate School of Life Sciences, Tohoku University) | Rab small GTPases in neuronal networks: dysregulation of Rabs in neurodegeneration | ||||
| May 24 (Thursday) 15:20～17:20 | |||||
| Room2 (Sapporo Geibunkan [Zuisetsu] 3F) |
NSF-02 | Intra- & into-the- brain propagation of α-synuclein: significance for the pathogenesis, progression and therapeutic target of Lewy body diseases | Hideki Mochizuki (Department of Neurology, Osaka University) Takahiko Tokuda (Department of Molecular Pathobiology of Brain Diseases, Kyoto Prefectural University of Medicine) |
Takahiko Tokuda (Department of Molecular Pathobiology of Brain Diseases, Kyoto Prefectural University of Medicine) |
Why don't you join us - hottest discussion on prion-like propagation of α-synuclein? |
| Ronald Melki (Centre National de la Recherche Scientifique (CNRS) / Paris-Saclay Institute of Neurosciences, France) |
Prion-like propagation of alpha-synuclein assemblies in the brain: from Structure to Function | ||||
| Norihito Uemura (Department of Neurology, Kyoto University Graduate School of Medicine) |
Pathological pathway via the olfactory bulb represents non-motor symptoms of Parkinson's disease | ||||
| Yuko Saito (Dept. Lab. Med., NCNP) |
Pathogenic mechanism on propagation of alpha- synuclein, a pathological point of view | ||||
| Kenjiro Ono (Department of Neurology, Showa University School of Medicine) |
Intra- & into-the- brain propagation of α-synuclein: Future Therapy | ||||
| Hideki Mochizuki (Department of Neurology, Osaka University) |
A refined concept alpha-synuclein dysregulation disease | ||||
Overcome the Challenges of Neurological Disorders
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 23 (Wednesday) 13:20～15:10 | |||||
| Room10 (Royton Sapporo [Heine's Hall] 2F) |
OC-02 | Research frontline of hereditary cerebellar ataxias | Yoshio Ikeda (Department of Neurology, Gunma University Graduate School of Medicine) Yuji Takahashi (National Center of Neurology and Psychiatry) |
Kinya Ishikawa (The Center for Personalized Medicine for Healthy Aging, Tokyo Medical and Dental University / Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University) |
SCA31: molecular pathogenesis and role of RNA chaperone |
| Peter K. Todd (University of Michigan, USA) |
Repeat associated Non-AUG initiated (RAN) translation in Fragile X-associated Tremor Ataxia Syndrome | ||||
| Hideshi Kawakami (Department of Epidemiology Research Institute for Radiology & Medicine Hiroshima University) |
SCA42: new calcium channelopathy | ||||
| Tetsuo Ashizawa (Houston Methodist Research Institute, USA) |
Molecular Pathology of Spinocerebellar Ataxia 10 | ||||
| May 26 (Saturday) 08:00～10:00 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
OC-05 | Gene & Cell Therapy for Neurological Diseases | Shin-ichi Muramatsu (Division of Neurology, Jichi Medical University) Hitoshi Okazawa (Medical Research Institute, Tokyo Medical and Dental University) |
Yu Miyazaki (Department of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University) | miRNA-mediated therapeutic approaches for neurodegenerative diseases |
| Nathalie Cartier (INSERM UMR1169 Université Paris Saclay, France) | AAV mediated gene therapy targeting brain cholesterol for Huntington disease | ||||
| Kohji Itoh (Department of Medicinal Biotechnology, Graduate School of Biomedical Sciences. Tokushima University / TR-SPRINT, AMED) | in vivo Gene Therapy for GM2 Gangliosidoses | ||||
| Jun Takahashi (Center for iPS Cell Research and Application) | Stem cell-based therapy for Parkinson's disease | ||||
Hot Topics
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 23 (Wednesday) 13:20～15:10 | |||||
| Room9 (Royton Sapporo [Regent Hall] 2F) |
HT-02 | Nucleic acid therapeutics | Takanori Yokota (Department of Neurology and Neurological Science,Tokyo Medical and Dental University) Yoshitsugu Aoki (Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)) |
Shinichi Torii (Biogen Japan Ltd.) | A first Antisense Oligonucleotide (ASO) therapy, Nusinersen, for Spinal Muscular Atrophy |
| Punit P. Seth (Ionis Pharmaceuticals, Inc., Canada) |
Engineering selectivity into therapeutic oligonucleotides through chemical design | ||||
| Tetsuya Nagata (Department of Neurology and Neurological Science, Tokyo Medical and Dental University) |
Recent progress of DNA/RNA heteroduplex oligonucleotide | ||||
| Tatsushi Toda (The University of Tokyo Graduate School of Medicine Dep.of Neurology) |
Antisense therapy for Fukuyama congenital muscular dystrophy | ||||
| May 24 (Thursday) 08:00～09:40 | |||||
| Room1 (Sapporo Geibunkan [Nitori Culture Hall] 1F) |
HT-01 | Large scale multicenter studies of dementia | Mikio Shoji (Department of Neurology, Hirosaki University Graduate School of Medicine) Hiroshi Mori (Dept of Clinical Neuroscience, Osaka City University Medical school / Tamiya Hospital) |
Mie Hirohata (Department of Neurology, Institute of Brain Science, Hirosaki University Graduate School of Medicine) | The Dominantly Inherited Alzheimer Network (DIAN)- Japan |
| Takeshi Iwatsubo (The University of Tokyo, Neuropathology, Unit for Early and Exploratory Clinical Development) |
A4 study | ||||
| Hiroshi Mori (Dept of Clinical Neuroscience, Osaka City University Medical school / Tamiya Hospital) |
Japanese preclinical AD clinical study (AMED preclinical study) | ||||
| Randall Bateman (Washington University is St. Louis School of Medicine, USA) |
THE DOMINANTLY INHERITED ALZHEIMER NETWORK, THE STUDY OF MUTATION CAUSED AD AND PREVENTION TRIALS | ||||
| May 24 (Thursday) 15:20～17:20 | |||||
| Room9 (Royton Sapporo [Regent Hall] 2F) |
HT-04 | Toward the eary diagnosis and treatment of Progressive Supranuclear Palsy | Ikuko Aiba (Department of Neurology, National Hospital Organization, Higashinagoya National Hospital) Takeshi Ikeuchi (Niigata University, Brain Research Institute) |
Günter Höglinger (German Center for Neurodegenerative Diseases Munich / Technical University Munich, Germany) | Clinical Diagnosis of Progressive supranuclear palsy - The Movement Disorder Society Criteria |
| Kensaku Kasuga (Department of Molecular Genetics, Brain Research Institute, Niigata University) | CSF Biomarkers for Diagnosis of PSP | ||||
| Keita Sakurai (Tokyo Metropolitan Geriatric Hospital) | Neuroimaging Biomarkers for Diagnosis in PSP | ||||
| Adam L. Boxer (University of California, San Francisco, USA) | Tau targeted therapeutics for neurodegeneration: a critical role for the archetypical tauopathy PSP | ||||
| May 26 (Saturday) 08:00～10:00 | |||||
| Room9 (Royton Sapporo [Regent Hall] 2F) |
HT-07 | Prion-like phenomenon: From myth to reality | Koji Yamanaka (Research Institute of Environmental Medicine, Nagoya University) Yohei Iguchi (Department of Neurology, Nagoya University) |
Per Borghammer (Dep. of Nuclear Medicine & PET Centre, Aarhus University Hospital, Denmark) |
Does Parkinson disease start in the gut? |
| John Ravits (Department of Neurosciences, University of California, San Diego, CA USA) |
Focality, stochasticity and neuro-anatomic propagation in ALS neurodegeneration | ||||
| Takafumi Hasegawa (Division of Neurology, Department of Neuroscience & Sensory Organs, Tohoku University Graduate School of Medicine) |
Endosomal pathway: a molecular basis for prion-like phenomenon in synucleinopathy | ||||
| Yohei Iguchi (Department of Neurology, Nagoya University) |
Exosome pathway: a key for clearance of pathological TDP-43 | ||||
Symposium
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 24 (Thursday) 08:00～09:30 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
S-10 | New approach to the cerebral small vessel disease | Toshiki Mizuno (Department of Neurology, Kyoto Prefectural University of Medicine) Hidekazu Tomimoto (Department of Neurology, Mie University Graduate School of Medicine) |
Andrew M. Demchuk (Calgary Stroke Program, University of Calgary, Canada) |
Acute stroke and stroke prevention management of cerebral small vessel disease |
| Hidekazu Tomimoto (Mie University Graduate School of Medicine, Department of Neurology) |
Neuropathological aspects of cerebral small vessel disease. | ||||
| Toshiki Mizuno (Department of Neurology, Kyoto Prefectural University of Medicine) |
Genetic background of the cerebral small vessel disease | ||||
| Masafumi Ihara (Department of Neurology, National Cerebral and Cardiovascular Center) |
Pre-clinical models of human cerebral small vessel disease: utility for clinical application | ||||
| May 24 (Thursday) 08:00～09:30 | |||||
| Room9 (Royton Sapporo [Regent Hall] 2F) |
S-11 | Current topics in acute encephalitis update – advance in diagnosis and treatment of autoimmune encephalitis | Satoshi Kamei (Division of Neurology, Department of Medicine, Nihon University School of Medicine) Hideto Nakajima (Division of Neurology, Department of Internal Medicine IV, Osaka Medical College) |
Josep Dalmau (ICREA, University of Barcelona and University of Pennsylvania, USA) |
NMDA receptor encephalitis and other antibody-mediated disorders of the synapse |
| Juichi Fujimori (Department of Neurology, Tohoku Medical and Pharmaceutical University) |
Acute encephalitis associated with anti-myelin oligodendrocyte glycoprotein (MOG) antibodies | ||||
| Susumu Kusunoki (Department of Neurology, Kindai University Faculty of Medicine) |
Bickerstaff brainstem encephalitis | ||||
| Makoto Yoneda (Faculty of Nursing and Social Welfare Sciences, Fukui Prefectural University) |
Limbic encephalitis with anti-NAE autoantibodies as a clinical subtype of Hashimoto's encephalopathy | ||||
| May 24 (Thursday) 15:20～17:20 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
S-17 | To pursue the best treatment of MG | Hiroyuki Murai (Department of Neurology, International University of Health and Welfare) Masakatsu Motomura (Medical Engineering Course, Nagasaki Institute of Applied Science) |
Hiroyuki Murai (Department of Neurology, International University of Health and Welfare) |
The treatment strategies of Japanese clinical guidelines for myasthenia gravis |
| Ted M. Burns (University of Virginia, USA) |
An approach to optimal treatments for patients with myasthenia gravis | ||||
| James F. Howard Jr (The University of North Carolina at Chapel Hill, USA) |
Complement Inhibition in the Treatment of Myasthenia Gravis | ||||
| Kimiaki Utsugisawa (Department of Neurology, Hanamaki General Hospital) |
How to achieve early treatment target in generalized myasthenia gravis | ||||
| May 25 (Friday) 08:00～09:30 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
S-23 | New fronteer of epileptogenicity: translatability between basic and clinical fields | Akio Ikeda (Department of Epilepsy, Movement Disorders and Physiology Kyoto University Graduate School of Medicine) Kazutaka Jin (Department of Epileptology, Tohoku University Graduate School of Medicine) |
Schuichi Koizumi (Dept Neuropharmacol, Interdisciplinary Grad Sch Med, Univ Yamanashi) | Characterization of epileptogenic astrocytes |
| Akio Ikeda (Department of Epilepsy, Movement Disorders and Physiology Kyoto University Graduate School of Medicine) | Glia and epileptogenicity from the clinical approach | ||||
| Takuya Takahashi (Department of Physiology, Yokohama City University, School of Medicine) | A novel PET tracer for AMPA receptors to visualize epileptic focus | ||||
| Kiyohito Terada (NHO Shizuoka Institute of Epilepsy and Neurological Disorders) |
Antagonists of AMPA receptor on epilepsy: from clinical point of view | ||||
| Kazuki Oi (Department of Neurology. Kyoto University Graduate School of Medicine) |
Very small dose of perampanel improved refractory cortical myoclonus | ||||
| May 25 (Friday) 08:00～09:30 | |||||
| Room9 (Royton Sapporo [Regent Hall] 2F) |
S-24 | Pathological basis and therapeutic strategy for neuropsychiatric symptoms | Hitoshi Shimada (Department of Functional Brain Imaging Research (DOFI), National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST)) Amane Tateno (Department of Neuropsychiatry, Nippon Medical School) |
Taku Hatano (Department of Neurology, Juntendo University School of Medicine) | Neuropsychiatric manifestations in movement disorders |
| Hitoshi Shinotoh (Neurology Clinic Chiba / Department of Brain Functional Imaging Research, National Institute of Radiological Sciences, National Insititutes for Quantum and Radiological Science and Technology) | Neural basis of neuropsychiatric symptoms in dementia | ||||
| Amane Tateno (Department of Neuropsychiatry, Nippon Medical School) | Psychiatric symptoms following brain trauma: CTE and PD-TBI | ||||
| Takaaki Mori (Department of Neuropsychiatry, Ehime University Graduate School of Medicine) | Molecular mechanism and clinical practice of therapy for psychotic symptoms | ||||
| May 25 (Friday) 13:45～15:45 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
S-28 | Cross-interaction of neuro-immune axis in autoimmune disorders of the CNS | Izumi Kawachi (Department of Neurology, Brain Research Institute, Niigata University) Ryo Yamasaki (Department of Neurology, Neurolgical Institute, Graduate School of Medical Sciences, Kyushu University) |
Ryo Yamasaki (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) | Revisiting glia as mothers and guardians of the central nervous system |
| Marco Prinz (University Freiburg, Institute of Neuropathology, Germany) | From yolk sac to neurodegeneration: the multiple facets of microglia | ||||
| Izumi Kawachi (Department of Neurology, Brain Research Institute, Niigata University) | Cross-interaction of neuro-immune axis in multiple sclerosis | ||||
| Kazuo Fujihara (Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience / Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine) | Cross-interaction of neuro-immune axis in NMO and neuroinflammatory disorders with MOG antibodies | ||||
| Marco Colonna (Washington University School of Medicine, USA) | TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease | ||||
| May 25 (Friday) 13:45～15:45 | |||||
| Room9 (Royton Sapporo [Regent Hall] 2F) |
S-29 | Alzheimer's disease up to date | Koji Abe (Department of Neurology, Okayama University) Atsushi Iwata (Department of Neurology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan) |
Thierry Bussière (Alzheimer & Dementia Research Unit, Biogen, USA) | Aducanumab and immunotherapy for the treatment of AD: what have we learnt from preclinical research? |
| Kawarabayashi Takeshi (Department of Neurology, Institute of Brain Science, Hirosaki University Graduate School of Medicine) |
Pathogenesis of Abeta oligomers in Alzheimer's disease, and foresights for therapy | ||||
| Hiroki Sasaguri (RIKEN Brain Science Institute) |
Generation of mutant presenilin 1 mice using a novel RNA-guided base editing technology | ||||
| Toru Yamashita (Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University) |
Chronic cerebral hypoperfusion accelerates Alzheimer's pathology in a novel mouse model | ||||
| Masato Hasegawa (Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science) |
Tau aggregation mechanisms and therapeutic strategies for AD | ||||
International Education Course
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 23 (Wednesday) 13:20～15:10 | |||||
| Room11 (Royton Sapporo [Crystal Room A] 2F) |
IE-01 | Essential knowledge and recent topics on neurological sleep-related disorders | Takuya Oguri (Department of Neurology, Tosei General Hospital) Koichi Hirata (Department of Neurology, Dokkyo Medical University) |
Aleksandar Videnovic (Massachusetts General Hospital, Harvard Medical School, USA) | Circadian rhythm sleep disorders in neurodegenerative diseases |
| Keisuke Suzuki (Department of Neurology, Dokkyo Medical University) | Restless Legs Syndrome in Neurological Disorders | ||||
| Takashi Kanbayashi (Department of Neuropsychiatry, Akita University Graduate School of Medicine / International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba) | Symptomatic Narcolepsy and Hypersomnolence with Orexin Deficiency | ||||
| Naoko Tachibana (Center for Sleep-related Disorders, Kansai Electric Power Hospital / Division of Sleep Medicine, Kansai Electric Power Medical Reserach Institute) | How could we make a proper diagnosis of RBD in Japan ? | ||||
| May 24 (Thursday) 15:20～17:20 | |||||
| Room11 (Royton Sapporo [Crystal Room A] 2F) |
IE-02 | Movement disorders in genral neurology | Mitsutoshi Yamamoto (Takamatsu Neurology Clinic) Francisco Cardoso (UFMG, Brazil) |
Francisco Cardoso (UFMG, Brazil) | Movement Disorders in Infectious Disorders. Francisco Cardoso. UFMG, Brazil. cardosofe@terra.com.br |
| Takahiro Iizuka (Department of Neurology, Kitasato University School of Medicine) | Movement disorders in autoimmune diseases | ||||
| Yasushi Shimo (Department of Neurology, Juntendo University School of Medicine) | Movement disorders in metabolic disorders | ||||
| Eduard Tolosa (Emeritus Professor at the university of Barcelona, Spain) | Drug induced movement disorders | ||||
| May 25 (Friday) 13:45～15:15 | |||||
| Room11 (Royton Sapporo [Crystal Room A] 2F) |
IE-03 | functional neurosurgery～update | Yasushi Shimo (Department of Neurology, Juntendo University School of Medicine) | Takaomi Taira (Department of Neurosurgery, Tokyo Women's Medical University) | Foremost Lines of Functional Neurosurgery |
| Kazumichi Yamada (Professor, Department of Functional Neurosurgery, Kumamoto University Hospital) | Current development of functional neurosurgery and its target disorders | ||||
| May 25 (Friday) 15:15～15:45 | |||||
| Room11(Royton Sapporo [Crystal Room A] 2F) | IE-04 | Therapeutic approach of Multiple Sclerosis | Masaaki Niino (Department of Clinical Research, Hokkaido Medical Center) | Ching-Piao Tsai (Taipei Beito Hospital / National Yang Ming University, Taiwan) | Therapeutic Approach of Multiple Sclerosis |
Sponsored Seminar
| Venue | No. | Theme | Chair | Speaker | Title |
|---|---|---|---|---|---|
| May 23 (Wednesday) 12:05～13:05 | |||||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
LS-03 | Luncheon Seminar 03 sponsored by Alexion Pharma GK |
Masakatsu Motomura (Professor, Doctor of Medicine Medical Engineering Course Department of Engineering, The Faculty of Engineering, Nagasaki Institute of Applied Science (NiAS)) | James F. Howard, Jr. (Distiguished Professor of Neuromusular Disease at The University of North Carolina at Chapel Hill) | See the possibility for generalized myasthenia gravis patients -What Soliris can do?- |
| May 24 (Thursday) 11:30～12:30 | |||||
| Room15 (SECH [Main Hall] 1F) |
LS-22 | Luncheon Seminar 22 sponsored by Biogen Japan Ltd. |
Toshio Saito (Toneyama National Hospita) |
Shafeeq S. Ladha, M.D. (Gregory W. Fulton ALS and Neuromuscular Disease Center Barrow Neurological Institute Phoenix, AZ) | Spinal muscular atrophy(SMA): Became a Treatable Disease |
Presentation Award Session
| Venue | No. | Session Title |
|---|---|---|
| May 23 (Wednesday) 15:19～16:31 | ||
| Room2 (Sapporo Geibunkan [Zuisetsu] 3F) |
AO-01 | Oral Presentation Award Session (Basic Research) |
| Room15 (SECH [Main Hall] 1F) |
AO-02 | Oral Presentation Award Session (Clinical Research) |
| May 23 (Wednesday) 17:40～18:46 | ||
| Poster Session (Royton Sapporo [Royton Hall] 3F) |
AP-01 | Poster Presentation Award Session (Basic Research) |
| Poster Session (Royton Sapporo [Royton Hall] 3F) |
AP-02 | Oral Presentation Award Session (Clinical Research) |
| Poster Session (Royton Sapporo [Royton Hall] 3F) |
APe-01 | Presentation Award Session for the International Participants |
General Session (Oral)
| Venue | No. | Session Title |
|---|---|---|
| May 23 (Wednesday) 15:25～16:25 | ||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
O-06 | Parkinsonism and Related disorders (thrapeutics and pathology) |
| Room9 (Royton Sapporo [Regent Hall] 2F) |
O-07 | Neuroscience (Molecular biology) |
| Room10 (Royton Sapporo [Heine's Hall] 2F) |
O-08 | Cerebellar ataxia and others (Biomarker, gene) |
| Room11 (Royton Sapporo [Crystal Room A] 2F) |
O-09 | Neurophysiology |
| Room12 (Royton Sapporo [Crystal Room B] 2F) |
O-10 | Clinical trial |
| May 24 (Thursday) 9:45～11:15 | ||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
O-19 | Cerebrovascular disease (Clinical research 1) |
| Room9 (Royton Sapporo [Regent Hall] 2F) |
O-20 | Neuroinfection (CJD and encephalitis) |
| Room10 (Royton Sapporo [Heine's Hall] 2F) |
O-21 | Peripheral neuropathy/Metabolic disorders |
| Room11 (Royton Sapporo [Crystal Room A] 2F) |
O-22 | Neuromuscular junction disorders and myopathy |
| Room12 (Royton Sapporo [Crystal Room B] 2F) |
O-23 | Neuropathology (Neurodegeneration) |
| May 25 (Friday) 9:45～11:15 | ||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
O-32 | Epilepsy |
| Room9 (Royton Sapporo [Regent Hall] 2F) |
O-33 | Parkinsonism and Related disorders (Biomarkers) |
| Room10 (Royton Sapporo [Heine's Hall] 2F) |
O-34 | Neurogenetics/ Gene therapy (Basic research) |
| Room11 (Royton Sapporo [Crystal Room A] 2F) |
O-35 | Dementia (Imaging) |
| Room12 (Royton Sapporo [Crystal Room B] 2F) |
O-36 | Neuroscience 1 |
| Room13 (Royton Sapporo [Crystal Room C] 2F) |
O-37 | Neuroimmunology (MS and NMO2) |
| May 26 (Saturday) 10:15～11:45 | ||
| Room8 (Royton Sapporo [Empress Hall] 2F) |
O-45 | Neurogenetics/ Gene therapy (Clinical research) |
| Room9 (Royton Sapporo [Regent Hall] 2F) |
O-46 | Neuroscience 2 |
| Room10 (Royton Sapporo [Heine's Hall] 2F) |
O-47 | Motor Neuron Disease (Basic research) |
| Room13 (Royton Sapporo [Crystal Room C] 2F) |
O-48 | Dementia (Basic research) |
General Session (Poster)
| Venue | No. | Session Title |
|---|---|---|
| May 23 (Wednesday) 17:40～18:46 | ||
| Poster Session (Royton Sapporo [Royton Hall] 3F) |
Pe-001 | Cerebrovascular disease (biomarker) |
| Pe-002 | Cerebrovascular disease (therapeutics) | |
| Pe-003 | Cerebrovascular disease (IVR) | |
| Pe-004 | Dementia (Risk factors) | |
| Pe-005 | Parkinsonism and Related disorders (Clinical research) | |
| Pe-006 | Parkinsonism and Related disorders (Symptoms) | |
| Pe-007 | Cerebellar ataxia and others (Quantitive assessment and other) | |
| Pe-008 | Parkinsonism and Related disorders (Molecular biology) | |
| Pe-009 | Neuroimmunology (MS and clinical research2) | |
| Pe-010 | Myopathy(IBM) | |
| Pe-011 | Metabolic disorders (Clinical genetics1) | |
| Pe-012 | Motor Neuron Disease (Pathogenesis) | |
| Pe-013 | Motor Neuron Disease (Basic research) | |
| Pe-014 | Peripheral neuropathy (Basic research) | |
| Pe-015 | Epilepsy (Elderly1) | |
| Pe-016 | Miscellaneus (Basic research1) | |
| Pe-017 | Miscellaneus (Basic research2) | |
| May 24 (Thursday) 17:35～18:50 | ||
| Poster Session (Royton Sapporo [Royton Hall] 3F) |
Pe-018 | Cerebrovascular disease (Basic research) |
| Pe-019 | Cerebrovascular disease (Prognostic factor) | |
| Pe-020 | Cerebrovascular disease (Biomarker) | |
| Pe-021 | Parkinsonism and Related disorders (DAT-SCAN and basic research) | |
| Pe-022 | Parkinsonism and Related disorders (Biomarkers) | |
| Pe-023 | Dementia (Basic research1) | |
| Pe-024 | Motor Neuron Disease (electrophysiological studies) | |
| Pe-025 | Cerebellar ataxia and others (Clinical research) | |
| Pe-026 | Parkinsonism and Related disorders (Basic research1) | |
| Pe-027 | Neuroimmunology （NMO2) | |
| Pe-028 | Parkinsonism and Related disorders (Biochemistry) | |
| Pe-029 | Peripheral neuropathy (CMT and CIDP) | |
| Pe-030 | Metabolic disorders (Mitochondrial diease and neutrition) | |
| Pe-031 | Neurophysiology | |
| Pe-032 | Cerebellar ataxia and others (Basic research and others) | |
| Pe-033 | Neuroimmunology (Basic research) | |
| Pe-034 | Myopathy (DMD/BMD1) | |
| Pe-035 | Epilepsy (Basic research) | |
| Pe-036 | Miscellaneus (Basic research3) | |
| May 25 (Friday) 16:00～17:12 | ||
| Poster Session (Royton Sapporo [Royton Hall] 3F) |
Pe-037 | Cerebrovascular disease (Imaging) |
| Pe-038 | Dementia (Biomarker) | |
| Pe-039 | Parkinsonism and Related disorders (DBS) | |
| Pe-040 | Dementia (Biomarker3) | |
| Pe-041 | Parkinsonism and Related disorders (PSP and dystonia) | |
| Pe-042 | Dementia (Basic research2) | |
| Pe-043 | Motor Neuron Disease (Clinical research) | |
| Pe-044 | Neuroimmunology (Clinical research1) | |
| Pe-045 | Parkinsonism and Related disorders (Biomarkers2) | |
| Pe-046 | Neuromuscular junction and other autoimmune disorders (Clinical research) | |
| Pe-047 | Parkinsonism and Related disorders (Basic research1) | |
| Pe-048 | Peripheral neuropathy (GBS and MFS1) | |
| Pe-049 | Neuroinfection (Clinical research) | |
| Pe-050 | Medical care and others 2 | |
| Pe-051 | Neuroimmunology (MS and basic research) | |
| May 26 (Saturday) 13:15～14:45 | ||
| Poster Session (Royton Sapporo [Royton Hall] 3F) |
Pe-052 | Cerebrovascular disease (Clinical research) |
| Pe-053 | Cerebrovascular disease (Cerebral Microangiopathy) | |
| Pe-054 | Dementia (Clinical research) | |
| Pe-055 | Parkinsonism and Related disorders (MRI2) | |
| Pe-056 | Dementia (Basic research3) | |
| Pe-057 | Parkinsonism and Related disorders (Rehabilitation) | |
| Pe-058 | Motor Neuron Disease (Genetics and physiology) | |
| Pe-059 | Parkinsonism and Related disorders (Basic research2) | |
| Pe-060 | Neuroimmunology (MS and clinical research1) | |
| Pe-061 | Myopathy (DMD/BMD2) | |
| Pe-062 | Peripheral neuropathy (Clinical research) | |
| Pe-063 | Headache (Clinical research) | |
| Pe-064 | Motor Neuron Disease (Genetics) | |
| Pe-065 | Miscellaneus | |
| Pe-066 | Myopathy (Basic research) | |
| Pe-067 | Neurophysiology (Basic research) | |
